Stockholders’ Equity (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
|
Jun. 09, 2026 |
Apr. 20, 2026 |
Apr. 05, 2026 |
Mar. 30, 2026 |
Jan. 30, 2026 |
Jan. 27, 2026 |
Jan. 14, 2026 |
Jan. 05, 2026 |
Jun. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Apr. 16, 2026 |
Feb. 19, 2026 |
Dec. 31, 2025 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from stock options exercised |
|
|
|
|
|
|
|
|
|
$ 561,808
|
|
$ 561,808
|
|
|
|
|
| Proceeds from exercise of stock options, net of subscription receivable |
|
|
|
|
|
|
|
|
|
|
|
533,924
|
|
|
|
|
| Subscription receivable |
|
|
|
|
|
|
|
|
$ 27,884
|
27,884
|
|
27,884
|
|
|
|
|
| Refund payable - cancelled stock option exercise |
|
|
|
|
|
|
|
|
$ 43,125
|
$ 43,125
|
|
$ 43,125
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
2,268,204
|
|
|
|
|
| Gross proceeds received |
|
|
|
|
|
|
|
|
|
|
|
$ 1,637,004
|
|
|
|
|
| Subscription per price |
|
|
|
|
|
|
|
|
$ 4.00
|
$ 4.00
|
|
$ 4.00
|
|
|
|
|
| Rights offering subscription proceeds in escrow |
|
|
|
|
|
|
|
|
$ 113,003
|
$ 113,003
|
|
$ 113,003
|
$ 6,704,304
|
|
|
6,704,304
|
| Antidilutive shares |
|
|
|
|
|
|
|
|
|
11,416,410
|
|
11,416,410
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antidilutive shares |
|
|
|
|
|
|
|
|
|
1,682,500
|
|
1,682,500
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antidilutive shares |
|
|
|
|
|
|
|
|
|
30,000
|
|
30,000
|
|
|
|
|
| Series A Right [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antidilutive shares |
|
|
|
|
|
|
|
|
|
4,498,204
|
|
4,498,204
|
|
|
|
|
| Series B Right [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antidilutive shares |
|
|
|
|
|
|
|
|
|
4,498,204
|
|
4,498,204
|
|
|
|
|
| Restricted Stock Units And Restricted Stock Awards [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antidilutive shares |
|
|
|
|
|
|
|
|
|
707,502
|
|
707,502
|
|
|
|
|
| Rights Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from subscription |
|
|
|
|
|
|
$ 9,072,816
|
|
|
|
|
|
|
|
|
|
| Units description |
|
|
|
|
|
|
each Unit consisting of one share of
common stock, one Series A Right to purchase one share of common stock at $5.00 per share (expiring July 18, 2026), and one Series B
Right to purchase one share of common stock at $6.00 per share (expiring November 20, 2026)
|
|
|
|
|
|
|
|
|
|
| Funds received in escrow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,704,304
|
| Gross proceeds received |
|
|
|
|
|
|
|
|
|
|
$ 2,368,512
|
|
|
|
|
|
| Issuance costs |
|
|
|
|
|
|
|
|
|
|
$ 1,009,318
|
|
|
|
|
|
| Deferred offering costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 164,807
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
$ 8,063,498
|
|
|
|
|
| Rights Offering [Member] | Series A Right [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
| Rights Offering [Member] | Series B Right [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
$ 6.00
|
|
|
|
|
|
|
|
|
|
| Rights Offering [Member] | Basic Subscriptions [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subscription rights |
|
|
|
|
|
|
1,247,086
|
|
|
|
|
|
|
|
|
|
| Rights Offering [Member] | Over-Subscriptions [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subscription rights |
|
|
|
|
|
|
1,021,118
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Units description |
|
|
|
|
|
Unit consisting of one share of common stock, one Series A Right to purchase one share of common stock at $5.00 per
share (expiring July 18, 2026), and one Series B Right to purchase one share of common stock at $6.00 per share (expiring November 20,
2026)
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
$ 8,323,748
|
|
|
|
|
|
|
|
|
|
|
| Number of units issued |
|
|
|
|
|
2,230,000
|
|
|
|
|
|
|
|
|
|
|
| Unit price per share |
|
|
|
|
|
$ 4.055
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering |
|
|
|
|
|
$ 9,042,650
|
|
|
|
|
|
|
|
|
|
|
| Issuance costs |
|
|
|
|
|
718,902
|
|
|
|
|
|
|
|
|
|
|
| Accountable expense |
|
|
|
|
|
$ 15,000
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering [Member] | Series A Right [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering [Member] | Series B Right [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
$ 6.00
|
|
|
|
|
|
|
|
|
|
|
| Consulting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price |
$ 6.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issuable |
800,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
| Stock to be issued description |
The
remaining 700,002 shares of common stock will be issued in nine equal monthly installments of 77,778 shares commencing in October
2026,subject to continued services.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate grant-date fair value of award |
$ 5,472,014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock options exercised |
|
|
|
|
|
|
|
|
197,800
|
|
|
|
|
|
|
|
| Proceeds from stock options exercised |
|
|
|
|
|
|
|
|
$ 561,808
|
|
|
|
|
|
|
|
| Proceeds from exercise of stock options, net of subscription receivable |
|
|
|
|
|
|
|
|
533,924
|
|
|
|
|
|
|
|
| Subscription receivable |
|
|
|
|
|
|
|
|
$ 27,884
|
$ 27,884
|
|
27,884
|
|
|
|
|
| Employees [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
$ 1.02
|
|
|
|
|
|
|
|
| Employees [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
$ 3.88
|
|
|
|
|
|
|
|
| Holder [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock options exercised |
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
| Refund payable - cancelled stock option exercise |
|
|
|
|
|
|
|
|
$ 43,125
|
43,125
|
|
43,125
|
|
|
|
|
| Restricted Stock Units And Restricted Stock Awards [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
727,638
|
|
$ 1,210,064
|
|
|
|
|
| Weighted-average remaining contractual life |
|
|
|
|
|
|
|
|
|
|
|
11 months 8 days
|
|
|
|
|
| Unrecognized compensation cost |
|
|
|
|
|
|
|
|
4,802,700
|
4,802,700
|
|
$ 4,802,700
|
|
|
|
|
| Aggregate intrinsic value |
|
|
|
|
|
|
|
|
$ 4,924,214
|
4,924,214
|
|
$ 4,924,214
|
|
|
|
|
| Restricted Stock Units And Restricted Stock Awards [Member] | Consulting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issuable |
800,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
| Stock to be issued description |
the remaining balance of 700,002 shares of common stock will be issued in
monthly installments of 77,778 commencing in October 2026 for continued services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
197,800
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
$ 2.84
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
664,800
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
192,238
|
|
$ 342,422
|
|
|
|
|
| Unrecognized compensation cost |
|
|
|
|
|
|
|
|
$ 2,017,943
|
2,017,943
|
|
$ 2,017,943
|
|
|
|
|
| Compensation expense recognition period |
|
|
|
|
|
|
|
|
|
|
|
3 years 7 months 2 days
|
|
|
|
|
| Weighted-average remaining contractual life |
|
|
|
|
|
|
|
|
|
|
|
5 years 6 months 21 days
|
|
|
|
|
| Intrinsic value |
|
|
|
|
|
|
|
|
7,622,297
|
7,622,297
|
|
$ 7,622,297
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
0
|
|
0
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,900,500
|
1,366,442
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8.48
|
$ 7.00
|
|
| Unrecognized compensation cost |
|
|
|
|
|
|
|
|
0
|
0
|
|
$ 0
|
|
|
|
|
| Weighted average remaining contractual life |
|
|
|
|
|
|
|
|
|
|
|
2 months 19 days
|
|
|
|
|
| Intrinsic value |
|
|
|
|
|
|
|
|
$ 13,193,556
|
$ 13,193,556
|
|
$ 13,193,556
|
|
|
|
|
| 2020 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of RSU issued |
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price |
|
$ 2.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Board Advisor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of RSU issued |
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
| Stock price |
|
|
|
|
|
|
|
$ 3.65
|
|
|
|
|
|
|
|
|
| Vested shares |
|
|
3,750
|
|
|
|
|
3,750
|
|
|
|
|
|
|
|
|
| 2020 Equity Incentive Plan [Member] | Restricted Stock [Member] | Officers [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of RSU issued |
|
|
|
|
150,000
|
|
|
|
|
|
|
|
|
|
|
|
| Value of awards granted |
|
|
|
|
$ 456,000
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 Equity Incentive Plan [Member] | Restricted Stock [Member] | Each Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of RSU issued |
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 Equity Incentive Plan [Member] | Restricted Stock [Member] | Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of RSU issued |
|
|
|
|
150,000
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price |
|
$ 3.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price |
|
|
|
$ 1.76
|
$ 3.04
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for future issuance |
|
|
|
|
|
|
|
|
5,343,425
|
5,343,425
|
|
5,343,425
|
|
|
|
|
| Number of options granted |
|
|
|
64,800
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Options vesting condition |
|
|
|
|
The options shall be subject to service-based vesting with twenty-five
percent (25%) of the shares underlying the option vesting on the first anniversary of the date of grant and the remaining seventy-five
percent (75%) vesting in thirty-six (36) equal monthly installments if the executive remains in continuous employment or service with
the Company on each applicable vesting date
|
|
|
|
|
|
|
|
|
|
|
|
| Estimated fair value market |
|
|
|
$ 98,500
|
$ 1,644,300
|
|
|
|
|
|
|
|
|
|
|
|
| Expected term |
|
|
|
6 years 3 days
|
7 years 3 days
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
$ 1.76
|
$ 3.04
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility |
|
|
|
116.20%
|
119.50%
|
|
|
|
|
|
|
|
|
|
|
|
| Risk-free rate |
|
|
|
4.07%
|
4.01%
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share |
|
|
|
$ 1.76
|
|
|
|
|
|
|
|
|
|
|
|
|